Search
for
Sort by
Research 211–240 of 1000+
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Identification of potential key genes and pathways associated with the Pashmina fiber initiation using RNA-Seq and integrated bioinformatics analysis
- Effects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture models
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata
- A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
- Immune cell regulation of the hair cycle
- Novel therapies for alopecia areata: The era of rational drug development
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- Pharmacological Treatment of Alopecia
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- Down‐regulation of Shh in the hair follicles of mice during chemotherapy‐induced hair loss is mediated by the JAK / STAT1 signaling pathway
- Treatment of frontal fibrosing alopecia: literature review 2020-2025
- Impacto del desequilibrio del microbioma del cuero cabelludo en la severidad de la alopecia areata, marcadores inflamatorios y cambios post-tratamiento
- Research Progress on the Application of Stem Cells in Hair Regeneration
- Alopecia areata
- CXCL12 inhibits hair growth through CXCR4
- Current and future pharmacotherapy for alopecia areata
- Registrars and Fellows Update Session 2
- INVESTIGATING THE MECHANISMS UNDERLYING THE PATHOGENESIS OF ALOPECIA AREATA
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of tofacitinib for treating alopecia areata
- Review of efficacy of baricitinib in the treatment of alopecia areata
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients.
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis
- Pathomechanisms of immune-mediated alopecia